Current location - Health Preservation Learning Network - Healthy weight loss - Tongrentang Niuhuang Qingxin Pill is temporarily included in the scope of basic medical insurance payment in Beijing.
Tongrentang Niuhuang Qingxin Pill is temporarily included in the scope of basic medical insurance payment in Beijing.
During the period of 20 15 to 20 19, this company was also involved in many disputes. For example, from 2065438 to March 2006, a consumer commissioned a testing agency to test the company's edible Ejiao, and the results were completely inconsistent with the actual feeding situation, which caused doubts. The company sent samples of relevant batches of products to China Food and Drug Inspection Institute for inspection, and the conclusion was that it met the identification requirements of China Pharmacopoeia 20 15.

The chest-opening Shunqi pills produced by this company have shown that the unqualified items are the difference in loading quantity. The company subsequently stated that it had recalled the batch of products. As a state-owned time-honored enterprise, the Group has a successful career and has 36 production bases, which can produce more than 2,600 kinds of medicines and health foods, among which Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Wuji Baifeng Pill are the most famous. Some people have analyzed that the intangible assets of state-owned enterprises' brands like this belong to state-owned assets, and we can't brand them everywhere because the leaders have interests with some enterprises or individuals, so that state-owned assets face great reputation, reputation damage risk and even economic compensation. The latest attempt is to launch the "Know Your Health" brand in the retail field. He opened a coffee shop in Shuangjing District, Beijing, with single products such as "Black Lycium Latte", "Motherwort Rose Latte" and "Camellia Chenpi American Style", and was rated as the old-school "Punk Health Bureau". The performance of listed companies in recent five years is relatively stable, and the inflection point appears at 20 19, and the profit level begins to decline. In the first half of 2020, the company's revenue and profit continued to decline compared with the same period of last year, with an operating income of 6 billion yuan, down 16. 1 1% compared with the same period of last year, and the net profit attributable to shareholders of listed companies decreased by 27.28%.